【レポートの概要（一部）】
1. Introduction to Cancer Vaacines
2. Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism
3. Adjuvants Therapy for Cancer Vaccines
4. Global Cancer Vaccines Market Overview
4.1 Current Market Scenario
4.2 Global Cancer Vaccine Drug Pipeline by Indication
5. Emergence of Personalized Cancer Vaccines
6. Public HPV Cancer Vaccination Program
7. Global Cancer Vaccines Market Dynamics
7.1 Favorable Market Parameters
7.1.1 Pottential Demand for Cancer Vaccines
7.1.2 Public Cancer Vaccination Program
7.1.3 Advancements in Development Technology
7.1.4 Personalized Cancer Vaccines
7.1.5 Myriad of Demographs for Cancer Vaccine Development
7.2 Commercialization Challenges
8. Global Cancer Vaccine Market Future Outlook
9. Bladder Cancer Vaccine Clinical Pipeline Insight by Company & Phase
9.1 Phase-II
10. Blood Cancer Vaccine Clinical Pipeline Insight by Company & Phase
10.1 Research till Preregistration
11. Brain Cancer Vaccine Clinical Pipeline Insight by Company & Phase
11.1 Preclinical Till Phase-III
12. Breast Cancer Vaccine Clinical Pipeline Insight by Company & Phase
12.1 Preclinical till Phase-III
13. Cancer Vaccine Clinical Pipeline Insight by Company & Phase
13.1 Research till Phase-II
14. Cervical Cancer Vaccine Clinical Pipeline Insight by Company & Phase
14.1 Phase-II
15. Colorectal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
15.1 Preclinical till Preregistration
16. Head and Neck Cancer Vaccine Clinical Pipeline Insight by Company & Phase
16.1 Preclinical till Phase-I/II
17. Liver Cancer Vaccine Clinical Pipeline Insight by Company & Phase
17.1 Phase-I till Phase-II
18. Lung Cancer Vaccine Clinical Pipeline Insight by Company & Phase
18.1 Preclinical till Phase-III
19. Oesophageal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
19.1 Phase-III
20. Ovarian Cancer Vaccine Clinical Pipeline Insight by Company & Phase
20.1 Preclinical till Phase-III
21. Pancreatic Cancer Vaccine Clinical Pipeline Insight by Company & Phase
21.1 Reseach till Phase-III
22. Prostate Cancer Vaccine Clinical Pipeline Insight by Company & Phase
22.1 Preclinical till Phase-III
23. Renal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
23.1 Phase-I till Phase-III
24. Sarcoma Vaccine Clinical Pipeline Insight by Company & Phase
24.1 Phase-II
25. Skin Cancer Vaccine Clinical Pipeline Insight by Company & Phase
25.1 Preclinical till Phase-III
26. Solid Tumours Vaccine Clinical Pipeline Insight by Company & Phase
26.1 Preclinical till Phase-II
27. Multiple Cancer Vaccine Clinical Pipeline Insight by Company & Phase
27.1 Preclinical till Phase-III
28. Marketed Cancer Vaccine Clinical Insight by Company & Indication
28.1 Bladder Cancer
28.1.1 BCG Bladder Cancer Vaccine (Immucyst® & TheraCys®)
28.1.2 Bladder Cancer Vaccine (PACIS®)
28.1.3 Bladder Cancer Vaccine – Organon Teknika
28.2 Cervical Cancer
28.2.1 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
28.3 Lung Cancer
28.3.1 BV NSCLC 001
28.3.2 Cadi 05 (Immuvac® & Mycidac-C™)
28.3.3 Racotumomab (Vaxira®)
28.4 Pancreatic Cancer
28.4.1 Tertomotide (LucaVax)
28.5 Prostate Cancer
28.5.1 Sipuleucel-T (Provenge®)
28.6 Renal Cancer
28.6.1 Renal Cancer Vaccine (Reniale®)
28.6.2 Vitespen (Oncophage®)
28.7 Skin Cancer
28.7.1 Melanoma Vaccine (MVax®)
28.7.2 Melanoma Vaccine (Melacine®)
28.8 Multiple Cancer
28.8.1 Human Papillomavirus Vaccine 9-Valent (V503) (GARDASIL®9)
28.8.2 Human Papillomavirus Vaccine Quadrivalent (Gardasil® & Silgard®)
29. Discontinued & Suspended Cancer Vaccine Drug Clinical Pipeline Insight
29.1 No Development Reported
29.2 Discontinued
29.3 Suspended
30. FDA Regulatory Framework for Cancer Vaccines Development & Marketing
30.1 Considerations for both Early and Late Phase Clinical Trials
30.1.1 Patient Population
30.1.2 Monitoring the Immune Response
30.1.3 Biomarkers as Evidence Of Efficacy
30.1.4 Adjuvants Used To Stimulate Immune Response
30.1.5 Multi-Antigen Vaccines
30.1.6 Disease Progression/Recurrence Immediately Or Shortly After The Initial Administration Of Cancer Vaccines
30.1.7 Concomitant and Subsequent Therapies
30.2 Considerations for Early Phase Clinical Trials
30.2.1 Starting Dose and Dosing Schedule
30.2.2 Booster and Maintenance Therapy
30.2.3 Dose Escalation
30.2.4 Single-Arm versus Randomized Phase 2 Trials In Early Development
30.3 Considerations for Late Phase Clinical Trials
30.3.1 Safety Profile from Early Phase Clinical Trials
30.3.2 Endpoints
30.3.3 Statistical Issues
30.3.4 Control Issues
30.3.5 Delayed Vaccine Effect
30.3.6 Autologous Vaccine Trials
30.3.7 Accelerated Approval Regulations
31. Competitive Landscape: Business Overview & Product Pipeline
31.1 Advaxis
31.2 AVAX Technologies
31.3 Celldex Therapeutics
31.4 Dendreon Corporation
31.5 Galena Biopharma
31.6 GlaxoSmithKline
31.7 ImmunoCellular Therapeutics
31.8 ImmunoGen
31.9 Inovio Pharmaceuticals
31.10 KAEL-GemVax
31.11 Liponova
31.12 MedImmune
31.13 Merck
31.14 NeoStem Oncology
31.15 NewLink Genetics
31.16 Northwest Biotherapeutics
31.17 Novartis
31.18 Peregrine Pharmaceuticals
31.19 Recombio
31.20 Roche
31.21 Sanofi
31.22 Seattle Genetics
31.23 Valeant Pharmaceuticals
【レポート販売概要】
■ タイトル：がんワクチンの世界市場及び治験インサイト■ 英文：Global Cancer Vaccine Market & Clinical Trial Insight
■ 発行日：42248
■ 調査会社：KuicK Research
■ 商品コード：KUIK51102
■ 調査対象地域：グローバル
- 農業用消毒剤の世界市場：次亜塩素酸塩＆ハロゲン、第4級アンモニウム化合物＆フェノール、酸化剤＆アルデヒドThe market size of agricultural disinfectants is projected to reach USD 2.11 Billion by 2021, growing at a CAGR of around 4.3% from 2016. The global agricultural disinfectants market has grown exponentially in the last few years. Increase in demand for animal products, emergence of greenhouse vegetable production and vertical farming, rising incidences of disease outbreaks among livestock, and ban …
- 世界の予測分析市場（不正行為、詐欺、リスク、マーケティング、オペレーション）The surging competition across various industry verticals need to look out for newer technologies to maintain their foothold in the ever-changing market. Regardless of the industry type and organizational size, big data is generated with every instance of consumer interaction. Predictive analytics ensures that this big data is scrutinized and correlated with present and past historical trends, to …
- ライムボレリア症ワクチンのグローバル市場機会分析（MarketVIEW: Lyme Borreliosis vaccines）Lyme Borreliosis (LB) or Lyme disease is caused by an infection with the bacterial spirochete Borrelia genospecies. The pathogen is transmitted to humans through the bite of infected Ixodes tick species. LB, which is endemic is large areas of Europe and North America, can cause a wide range of disease symptoms which range from a mild treatable rash to serious complications of the neurological syst …
- 世界の企業向けNAS市場動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Network Attached Storage (NAS) market to grow at a CAGR of 22.85 percent CAGR percent over the period 2012-2016. One of the key factors contributing to this market growth is the improved cost-efficiency caused by the adoption of NAS solutions. The Global Enterprise NAS market has also been witnessing increased adoption of NAS solutions from small …
- Wintershall Holding GmbH：石油・ガスの開発・生産動向及びコスト分析- 2012Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界のピアノ市場2015Global Piano Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Piano industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Piano market analysis is provided for the international markets including development trends, competitive landscape analysis, and …
- 2014年戦略提言：アメリカのポイントオブケア（POC）血液及びフローサイトメトリー市場This new 238-page report from Venture Planning Group contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers deve …
- システムトレードの世界市場2016-2020About the Algorithmic Trading Market 2016-2020 Modern financial markets use advanced mathematical models to arrive at (and execute) transaction decisions. Such automated technologies are referred to as high-speed algorithmic trading. These methods determine the optimal time for an order to be placed so as to generate the least impact on stock prices. Large institutional investors use algorithmic t …
- 幹細胞治療の世界市場2018-2022About Stem Cell Therapy Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine. Technavio’s analysts forecast the Global Stem Cell Therapy Market to grow at a CAGR of 10.52% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the stem cell ther …
- RFIDソリューション及び市場機会2012：RFID Solutions and Market Opportunities 2012RFID Solutions and Market Opportunities is the most comprehensive RFID research package available in the market. It includes many reports in the core area of RFID as well as Near Field Communications (NFC), Personal Area Networks (PAN), Ultra-wide Band (UWB), and related areas (see Table of Contents for full list). This package represents complete market knowledge for service providers, suppliers, …
- 固定工具インサートの世界市場2017-2021ABSTRACTAbout Stationary Tool Inserts Stationary tool inserts used for cutting and shaping of metals and other materials were also developed as a part of the Industrial Revolution. These inserts ensure the effective manufacturing of critical and intricate components, with ease and utmost precision. These tool inserts form an indispensable part of machine tools that are either numerically or conven …
- 圧力リリーフ弁のグローバル市場動向（2014-2018）About Global Pressure Relief Valves market Pressure relief valves are the valves that release pressure from the pressurized vessel when the force exerted onto the disc is greater than the process inlet force. Industries such as Oil and Gas, Power, Chemical, Food and Beverages, Pulp and Paper, and Pharmaceutical require installation of pressure relief valves in their main production systems to cont …
- UK Hospital Clinical Chemistry and Immunodiagnostics Market 2014This new report from Venture Planning Group contains 523 pages, 64 tables, and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant …
- 統合ネットワーク管理の世界市場：有線、無線The unified network management market is estimated to grow from USD 5.01 Billion in 2016 to USD 12.32 Billion by 2021. The market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) of 19.7% owing to the rising usage of unified networking solutions among organizations to manage and control wireline or wireless networking activities. Companies are deploying unified networking so …
- 赤ちゃん用製品の世界市場分析：製品別（化粧品・トイレタリー、ベビーフード、赤ちゃんの安全と利便性）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ）、セグメント予測、2014-2025The global baby product market is expected to reach USD 121.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising spending capability in matured economies of North America and Europe will augment industry growth over the next nine years. Increasing birthrate in emerging economies of Asia Pacific including India and China is anticipated to drive the demand for infant item …
